CRISPR Gene Editing Tools - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511249239

Publication Date:

November 27, 2024

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Gene Editing tools for CRISPR Gene Editing
The global market for CRISPR Gene Editing Tools was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR Gene Editing Tools was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR Gene Editing Tools was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for CRISPR Gene Editing Tools was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of CRISPR Gene Editing Tools include Abcam, Inc., Agilent Technologies, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., New England Biolabs, Inc., Origene Technologies, Inc. and Rockland Immunochemicals, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Editing Tools, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CRISPR Gene Editing Tools by region & country, by Type, and by Application.
The CRISPR Gene Editing Tools market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Editing Tools.
麻豆原创 Segmentation
By Company
Abcam, Inc.
Agilent Technologies, Inc.
CRISPR Therapeutics AG
GeneCopoeia, Inc.
GenScript Biotech Corporation
Integrated DNA Technologies, Inc.
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Thermo Fisher Scientific, Inc.
Segment by Type:
Cas Nuclease
Guide RNA
DNA ligase
Restriction Endonuclease
Others
Segment by Application
Agricultural
Biomedical
Industrial
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CRISPR Gene Editing Tools manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CRISPR Gene Editing Tools in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CRISPR Gene Editing Tools in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 CRISPR Gene Editing Tools Product Introduction
1.2 Global CRISPR Gene Editing Tools 麻豆原创 Size Forecast
1.3 CRISPR Gene Editing Tools 麻豆原创 Trends & Drivers
1.3.1 CRISPR Gene Editing Tools Industry Trends
1.3.2 CRISPR Gene Editing Tools 麻豆原创 Drivers & Opportunity
1.3.3 CRISPR Gene Editing Tools 麻豆原创 Challenges
1.3.4 CRISPR Gene Editing Tools 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CRISPR Gene Editing Tools Players Revenue Ranking (2023)
2.2 Global CRISPR Gene Editing Tools Revenue by Company (2019-2024)
2.3 Key Companies CRISPR Gene Editing Tools Manufacturing Base Distribution and Headquarters
2.4 Key Companies CRISPR Gene Editing Tools Product Offered
2.5 Key Companies Time to Begin Mass Production of CRISPR Gene Editing Tools
2.6 CRISPR Gene Editing Tools 麻豆原创 Competitive Analysis
2.6.1 CRISPR Gene Editing Tools 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by CRISPR Gene Editing Tools Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Editing Tools as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cas Nuclease
3.1.2 Guide RNA
3.1.3 DNA ligase
3.1.4 Restriction Endonuclease
3.1.5 Others
3.2 Global CRISPR Gene Editing Tools Sales Value by Type
3.2.1 Global CRISPR Gene Editing Tools Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global CRISPR Gene Editing Tools Sales Value, by Type (2019-2030)
3.2.3 Global CRISPR Gene Editing Tools Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Agricultural
4.1.2 Biomedical
4.1.3 Industrial
4.1.4 Others
4.2 Global CRISPR Gene Editing Tools Sales Value by Application
4.2.1 Global CRISPR Gene Editing Tools Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global CRISPR Gene Editing Tools Sales Value, by Application (2019-2030)
4.2.3 Global CRISPR Gene Editing Tools Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global CRISPR Gene Editing Tools Sales Value by Region
5.1.1 Global CRISPR Gene Editing Tools Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global CRISPR Gene Editing Tools Sales Value by Region (2019-2024)
5.1.3 Global CRISPR Gene Editing Tools Sales Value by Region (2025-2030)
5.1.4 Global CRISPR Gene Editing Tools Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America CRISPR Gene Editing Tools Sales Value, 2019-2030
5.2.2 North America CRISPR Gene Editing Tools Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe CRISPR Gene Editing Tools Sales Value, 2019-2030
5.3.2 Europe CRISPR Gene Editing Tools Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific CRISPR Gene Editing Tools Sales Value, 2019-2030
5.4.2 Asia Pacific CRISPR Gene Editing Tools Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America CRISPR Gene Editing Tools Sales Value, 2019-2030
5.5.2 South America CRISPR Gene Editing Tools Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa CRISPR Gene Editing Tools Sales Value, 2019-2030
5.6.2 Middle East & Africa CRISPR Gene Editing Tools Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CRISPR Gene Editing Tools Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions CRISPR Gene Editing Tools Sales Value
6.3 United States
6.3.1 United States CRISPR Gene Editing Tools Sales Value, 2019-2030
6.3.2 United States CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.3.3 United States CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe CRISPR Gene Editing Tools Sales Value, 2019-2030
6.4.2 Europe CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China CRISPR Gene Editing Tools Sales Value, 2019-2030
6.5.2 China CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.5.3 China CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan CRISPR Gene Editing Tools Sales Value, 2019-2030
6.6.2 Japan CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea CRISPR Gene Editing Tools Sales Value, 2019-2030
6.7.2 South Korea CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia CRISPR Gene Editing Tools Sales Value, 2019-2030
6.8.2 Southeast Asia CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India CRISPR Gene Editing Tools Sales Value, 2019-2030
6.9.2 India CRISPR Gene Editing Tools Sales Value by Type (%), 2023 VS 2030
6.9.3 India CRISPR Gene Editing Tools Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abcam, Inc.
7.1.1 Abcam, Inc. Profile
7.1.2 Abcam, Inc. Main Business
7.1.3 Abcam, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.1.4 Abcam, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.1.5 Abcam, Inc. Recent Developments
7.2 Agilent Technologies, Inc.
7.2.1 Agilent Technologies, Inc. Profile
7.2.2 Agilent Technologies, Inc. Main Business
7.2.3 Agilent Technologies, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.2.4 Agilent Technologies, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent Technologies, Inc. Recent Developments
7.3 CRISPR Therapeutics AG
7.3.1 CRISPR Therapeutics AG Profile
7.3.2 CRISPR Therapeutics AG Main Business
7.3.3 CRISPR Therapeutics AG CRISPR Gene Editing Tools Products, Services and Solutions
7.3.4 CRISPR Therapeutics AG CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.3.5 GeneCopoeia, Inc. Recent Developments
7.4 GeneCopoeia, Inc.
7.4.1 GeneCopoeia, Inc. Profile
7.4.2 GeneCopoeia, Inc. Main Business
7.4.3 GeneCopoeia, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.4.4 GeneCopoeia, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.4.5 GeneCopoeia, Inc. Recent Developments
7.5 GenScript Biotech Corporation
7.5.1 GenScript Biotech Corporation Profile
7.5.2 GenScript Biotech Corporation Main Business
7.5.3 GenScript Biotech Corporation CRISPR Gene Editing Tools Products, Services and Solutions
7.5.4 GenScript Biotech Corporation CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.5.5 GenScript Biotech Corporation Recent Developments
7.6 Integrated DNA Technologies, Inc.
7.6.1 Integrated DNA Technologies, Inc. Profile
7.6.2 Integrated DNA Technologies, Inc. Main Business
7.6.3 Integrated DNA Technologies, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.6.4 Integrated DNA Technologies, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.6.5 Integrated DNA Technologies, Inc. Recent Developments
7.7 New England Biolabs, Inc.
7.7.1 New England Biolabs, Inc. Profile
7.7.2 New England Biolabs, Inc. Main Business
7.7.3 New England Biolabs, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.7.4 New England Biolabs, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.7.5 New England Biolabs, Inc. Recent Developments
7.8 Origene Technologies, Inc.
7.8.1 Origene Technologies, Inc. Profile
7.8.2 Origene Technologies, Inc. Main Business
7.8.3 Origene Technologies, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.8.4 Origene Technologies, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.8.5 Origene Technologies, Inc. Recent Developments
7.9 Rockland Immunochemicals, Inc.
7.9.1 Rockland Immunochemicals, Inc. Profile
7.9.2 Rockland Immunochemicals, Inc. Main Business
7.9.3 Rockland Immunochemicals, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.9.4 Rockland Immunochemicals, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.9.5 Rockland Immunochemicals, Inc. Recent Developments
7.10 Thermo Fisher Scientific, Inc.
7.10.1 Thermo Fisher Scientific, Inc. Profile
7.10.2 Thermo Fisher Scientific, Inc. Main Business
7.10.3 Thermo Fisher Scientific, Inc. CRISPR Gene Editing Tools Products, Services and Solutions
7.10.4 Thermo Fisher Scientific, Inc. CRISPR Gene Editing Tools Revenue (US$ Million) & (2019-2024)
7.10.5 Thermo Fisher Scientific, Inc. Recent Developments
8 Industry Chain Analysis
8.1 CRISPR Gene Editing Tools Industrial Chain
8.2 CRISPR Gene Editing Tools Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 CRISPR Gene Editing Tools Sales Model
8.5.2 Sales Channel
8.5.3 CRISPR Gene Editing Tools Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abcam, Inc.
Agilent Technologies, Inc.
CRISPR Therapeutics AG
GeneCopoeia, Inc.
GenScript Biotech Corporation
Integrated DNA Technologies, Inc.
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Thermo Fisher Scientific, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.